Articles On Avita Medical (ASX:AVH)

Title Source Codes Date
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Stockhead AVH 1 year ago
AVITA Medical (ASX:AVH) appoints James Corbett as CEO

Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He...

themarketherald.com.au AVH 1 year ago
3 ASX All Ordinaries shares defying today’s rout to surge higher

The S&P/ASX All Ordinaries Index (ASX: XAO) is deep in the red today after a hot US inflation report sent Wall Street into a tailspin overnight. At the time of writing, the All Ords index has slipped 2.6% to 7,065 points. The S&P/A...

Motley Fool AVH 1 year ago
Market Highlights: US bans Nvidia chips in China; and 5 ASX small caps to watch on Friday

Local markets set to open higher, Friday Late rally sees the S&P 500 close ahead, first time in five days  US China trade war flares as chipmaker banned  Local shares are set to open higher on Friday. At 8am AEST, the ASX 200 Septembe...

Stockhead AVH 1 year ago
ScoPo’s Powerplays: Reporting season positive as ASX health stocks head in right direction

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

Stockhead AVH 1 year ago
AVITA Medical announces topline results for RECELL System trial

Regenerative medicine company AVITA Medical (ASX:AVH) has announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin harve...

BiotechDispatch AVH 1 year ago
The Monday Report – 15 August 2022

By Greg Peel Just a Scare Wall Street had shot up initially on a lower PPI print on Thursday night before rolling over to close flat, suggesting maybe the comeback rally had run its course. The local market thus ran scared from the open, dr...

FNArena AVH 1 year ago
Closing Bell: It must be Funky Friday, because it’s smelling pretty crook at the end of the day

The benchmark grumbles to a slovenly 0.7% slide Aussie bond yields have risen 13 basis points as recession chatter continues Domino’s sinks after getting laughed out of Italy The ASX has been consistently indolent, even – dare we say it –...

Stockhead AVH 1 year ago
ASX Close: End-of-week selling dents longest weekly win run since 2021

The share market secured its longest weekly winning streak in more than a year after weathering profit-taking today after Wall Street’s “peak-inflation” relief rally ran out of gas. The S&P/ASX 200 eked out a fourth week of gains. A...

themarketherald.com.au AVH 1 year ago
ASX Update: Weekly gain shrinks as month-long rally loses heat

The share market came close to erasing its gains for the week following soft leads from Wall Street and a bout of profit-taking at two-month highs. The S&P/ASX 200 remained on track for a fourth week of gains despite falling 42 point...

themarketherald.com.au AVH 1 year ago
ASX Health Stocks: Avita tumbles 16pc as RECELL study results disappoint investors

Avita Medical’s top line results on RECELL disappoint investors Cynata has completed a strategic review, and will terminate its Covid-19 study Resmed’s revenue grows in FY22 Shares in regenerative cells biotech Avita Medical (ASX:AVH) plu...

Stockhead AVH 1 year ago
Avita share price dives 16% on net loss

The AVITA Medical Inc (ASX: AVH) share price is falling on the back of the company’s financial results. The medical technology company’s share price is currently $1.895, a 16.5% fall. For perspective, the S&P/ASX 200 Index (ASX...

Motley Fool AVH 1 year ago
AVITA Medical (ASX:AVH) reports positive results from soft tissue trial

AVITA Medical (AVH) reports positive top line results for its RECELL trial in patients with soft-tissue injuries The company released results from its randomised, controlled trial which evaluated the effectiveness of the RECELL system when...

themarketherald.com.au AVH 1 year ago
Top 10 at 10: This ASX lithium battery stock is on a tear in early trade

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead AVH 1 year ago
Market Highlights: Wall St fades, a BTC rally, 5 ASX small caps to watch on Friday

The ASX 200 will open lower on Friday Wall Street fades away late in the trading day Bitcoin has rallied further Local shares are set to open lower today. At 8am AEST, the ASX 200 August futures contract is pointing down by 0.35%. Overnig...

Stockhead AVH 1 year ago
ASX Today: Gains ahead as US cheers inflation slowdown

Aussie stocks were set to open sharply higher after inflation slowed more than expected in the US, easing pressure on the Federal Reserve to raise rates aggressively. A relief rally lifted two of Wall Street’s three main indices by more...

themarketherald.com.au AVH 1 year ago
ASX Today: US jobs blowout to weigh as reporting season amps up

Aussie stocks were poised for a cautious start to the week following a mixed close in the US after blowout jobs figures dashed hopes of a slowdown in interest rate hikes.   Surging bond yields helped drive the S&P 500 and Nasdaq Comp...

themarketherald.com.au AVH 1 year ago
Closing Bell: Mrs Pelosi goes to Taipei; Pfizer comes back for ResApp

The ASX 200 is down, the XEC surged late, up 1.5%  Tech stocks rise, Cons discretionary and energy dragging US Futures flat, Chinese markets higher on Pelosi goes to Taipei day   Ahead of the close here in Sydney, US Futures connected to...

Stockhead AVH 1 year ago
Why is the Polynovo share price popping 7% on Wednesday?

The Polynovo Ltd (ASX: PNV) share price is trading in the green during the afternoon session on Wednesday. At the time of writing, shares in the medical devices company are trading 6.33% higher at $1.68 apiece. Earlier this afternoon, t...

Motley Fool AVH 1 year ago
Why is the Avita Medical share price tracking 20% higher today?

The AVITA Medical Inc (ASX: AVH) share price has shot well into the green in lunchtime trade on Wednesday. At the time of writing, the company’s shares are 19.88% higher at $2.05 apiece on no news. In broader market moves, the S&P...

Motley Fool AVH 1 year ago
Why did the Nasdaq share price rocket 19% in July?

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Nasdaq I...

Motley Fool AVH 1 year ago
Metalstech share price soars 11% on ‘milestone achievement’

The Metalstech Ltd (ASX: MTC) share price is lifting into the green in early trade on Wednesday. At the time of writing, the gold and lithium explorer is trading around 11% higher at 40.5 cents apiece following the release of a company a...

Motley Fool AVH 1 year ago
ASX share price sinks as CHESS replacement delayed

The ASX Ltd (ASX: ASX) share price is in the red. Its tumble comes after the market operator announced that its long-awaited CHESS replacement likely won’t be operational until at least 2024. The company has also commissioned an independe...

Motley Fool AVH 1 year ago
Why did the Uber share price surge 18% today?

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Shares o...

Motley Fool AVH 1 year ago
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022

What are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up for ASX biotechs in 2022 Risks of investing in biotechs Historical data shows that biotech is one the best sectors to put your money in ov...

Stockhead AVH 1 year ago
Bell Potter names 2 of the best ASX healthcare shares to buy in FY23

This month I’ve been looking at a number of shares that Bell Potter has rated as its top picks for FY 2023. You can read about its tech picks here and its energy picks here. On this occasion, let’s take a look at a couple of ASX health...

Motley Fool AVH 1 year ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead AVH 1 year ago
Morningstar confident of healthcare recovery as sector outperforms ASX 200 in Q3

Morningstar bullish on ability of ASX healthcare sector to come back S&P ASX 200 Health Care Index outperformed S&P ASX 200 by more than 8% in Q3FY22 Morningstar picks Avita Medical and Sigma Healthcare as two standouts Morningst...

Stockhead AVH 1 year ago
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Stockhead AVH 1 year ago
AVITA wins best emerging company investor relations award

Regenerative medicine company AVITA Medical (ASX:AVH) has won the Australasian Investor Relations Association Award for Best Investor Relations by a company in the S&P/ASX Emerging Companies Index.

BiotechDispatch AVH 1 year ago
Avita Medical (ASX:AVH) decreases total revenue in Q1

Avita Medical (AVH) reports a 14 per cent year-on-year decrease in net revenue to $7.5 million in the March quarter Despite this, commercial sales rose 61 per cent to $7.4 million, reflecting sales of its RECELL system which treats acute t...

themarketherald.com.au AVH 1 year ago
Avita Medical share price tumbles 7% on declining Q1 revenue

The Avita Medical Inc (ASX: AVH) share price is down 7.2% to $1.62 in early trade. Avita focuses on regenerative medicines. Its spray-on Recell medicine is used to treat burn patients. Below we look at the ASX healthcare share’s first-quar...

Motley Fool AVH 1 year ago
Bargain Barrel: Buys in the battered ASX biotech sector? Ask Boreham!

The deep sell down of the US biotech sector has resulted in the valuation of many of the ASX-listed life science plays looking a tad sickly, too. Arguably, many of them were overvalued in the first place. But in many cases the companies ar...

Stockhead AVH 1 year ago
4 ASX healthcare shares at 52-week lows

Plenty of ASX healthcare shares fell to 52-week lows today. The industry has not been immune to the ASX share market selloff. There is ongoing volatility with investors keeping an on the Russian conflict with Ukraine, the sanctions and the...

Motley Fool AVH 2 years ago
3 promising small cap ASX shares to watch

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Motley Fool AVH 2 years ago
Top 10 at 10: The ASX stocks clinching an early win today

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead AVH 2 years ago
ASX Health Stocks: Avita to start selling RECELL across the US to treat extensive burns

The ASX 200 Health Index (XHJ) is trading lower by 0.30% at the time of writing, compared to the broader index which is up by 0.90%. Regenerative medicine company, Avita Medical (ASX:AVH), has been awarded a purchasing contract from Premier...

Stockhead AVH 2 years ago
Closing Bell: Climbing over 3%, the ASX Small Cap index is a Tuesday juggernaut

The ASX Emerging Companies index (XEC) ran free on Tuesday, climbing over 3%, apparently unrestrained by the various macro or geopolitical issues bothering the rest of us. That said, the more gown up ASX200 also lifted on Tuesday, gaining a...

Stockhead AVH 2 years ago
Avita Medical (ASX:AVH) shares surge as net loss decreases

Skin regeneration specialist Avita Medical (AVH) bolsters revenue and shrinks its net loss for the six months to the end of December 2021 The company says over this time period, it grew revenue by 37 per cent to US$14 million (A$19 million...

themarketherald.com.au AVH 2 years ago
Avita Medical (ASX:AVH) share price soars 23% as earnings stage a comeback

The Avita Medical Inc (ASX: AVH) share price is skyrocketing today after the company released its financial results for a six month “transition period” ended 31 December 2021. The company announced in December 2021 that it wanted to change...

Motley Fool AVH 2 years ago
ASX Health Stocks: Cannabis biotech Avecho begins dosing patients in CBD gel study to treat osteoarthritis

The ASX 200 Health Index (XHJ) is trading higher by 0.55% at the time of writing, compared to the broader index which is up by 0.45%. Cannabis stock Avecho Biotechnology (ASX:AVE) announced today that patient dosing has commenced for its Ph...

Stockhead AVH 2 years ago
Is it time to buy Cathie Wood’s beaten-up biotech companies (BATS:ARKG)?

Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly for a year. The ETF peaked at US$112.23 on the 8th of February 2021, and is down 60% to US$45.99.   Source: Yahoo FinanceHea...

Rask Media AVH 2 years ago
Buying Opportunities Beckon Amid Biotech Bloodbath

ShareCafeBuying Opportunities Beckon Amid Biotech Bloodbath The sharp retreat in global biotech valuations is creating rare buying opportunities as investors flee ‘riskier’ sectors on the back of rising interest rates, dwindling liquidity a...

ShareCafe AVH 2 years ago
The Montgomery Fund’s key drivers of performance in 2021

In this week’s video insight Joseph discusses the key drivers of The Montgomery Fund’s performance for calendar year 2021. Overall, 2021 was a successful year for The Montgomery Fund. The total return of 25.1 per cent after fees represented...

Montgomery AVH 2 years ago
AVITA Medical completes enrolment in trial for soft-tissue reconstruction

Regenerative medicine company AVITA Medical (ASX:AVH) has completed enrollment in its pivotal trial for the use of the RECELL System for soft tissue reconstruction.

BiotechDispatch AVH 2 years ago
The Montgomery Fund – year in review

The Montgomery Fund (The Fund) closed an impressive 2021, outperforming the S&P/ASX 300 Accumulation Index by 7.61 per cent, after fees. Over the year The Fund also paid a solid distribution at 30 June and a smaller one at 31 December,...

Montgomery AVH 2 years ago
Why the AVITA (ASX:AVH) share price is charging higher today

The AVITA Medical Inc (ASX: AVH) share price is pushing higher on Tuesday morning. In morning trade, the regenerative medicine company’s shares are up 3.5% to $3.25. Why is the AVITA share price pushing higher? Investors have been bidding...

Motley Fool AVH 2 years ago
AVITA Medical (ASX:AVH) predicts positive quarter

AVITA Medical Inc. (AVH) releases preliminary unaudited estimates of its top line results for its latest financial quarter AVITA’s total revenue increased 35 per cent to US$6.9 million, compared to US$5.1 million over the same quarter last...

themarketherald.com.au AVH 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Friday

Selling pressure eases on Wall Street After the big tumble on Wednesday following the release of Fed’s rate cut plans, US stocks fell more modestly overnight. All three major benchmarks were down – the S&P 500 by 0.10%, the Dow by 0.47%...

Stockhead AVH 2 years ago
AVITA Medical (ASX:AVH) establishes proof of concept for skin rejuvenation

AVITA Medical (AVH) reports its preclinical data establishes proof of concept in two key areas of cell-based gene therapy – skin rejuvenation and epidermolysis bullosa Data shows successful regeneration of the skin when AVITA’s Spray-On Sk...

themarketherald.com.au AVH 2 years ago